Showing items 1351-1375 of 2549 (102 Page(s) Totally)
<< < 50 51 52 53 54 55 56 57 58 59 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-05-12T02:50:18Z |
Dependence of nanocrystal dimensionality on the polymer nanomorphology, anisotropic optical absorption, and carrier transport in P3HT:TiO2 bulk heterojunctions
|
HSUEN-LI CHEN; HSUEN-LI CHEN;Chen, C.-W.;Chu, M.-W.;Chang, C.-P.;Pao, C.-W.;Lee, C.-K.;Li, S.-S.;Yeh, Y.-C.;Chen, H.-L.;Yu, C.-C.;Du, C.-H.;Huang, C.-L.;Ho, P.-H.;Lin, C.-C.; Lin, C.-C.; Ho, P.-H.; Huang, C.-L.; Du, C.-H.; Yu, C.-C.; Chen, H.-L.; Yeh, Y.-C.; Li, S.-S.; Lee, C.-K.; Pao, C.-W.; Chang, C.-P.; Chu, M.-W.; Chen, C.-W. |
| 臺大學術典藏 |
2020-05-05T08:40:28Z |
A novel DNA selection and direct extraction process and its application in DNA recombination
|
Wang A.-B.; Cheng C.-W.; Lin I.-C.; Lu F.-Y.; Tsai H.-J.; Lin C.-C.; Yang C.-H.; Pan P.-T.; Kuan C.-C.; Chen Y.-C.; Lin Y.-W.; Chang C.-N.; Wu Y.-H.; Kurniawan T.; Lin C.-W.; Wo A.M.; Chen L.-C.; AN-BANG WANG |
| 臺大學術典藏 |
2020-05-04T08:08:57Z |
A middleware architecture to improve the efficiency of web-based telemedicine application
|
Lin, C.-C.; Hsu, W.-H.; Chen, J.-H.; Chen, H.-S.; Chen, C.-Y.; Hou, S.-M.; WINSTON HSU |
| 臺大學術典藏 |
2020-05-04T08:02:31Z |
Novel approach for finding optimization opportunities in multicore architectures
|
PANGFENG LIU; Lin, C.-C.;Liu, P.;Wu, J.-J.; Lin, C.-C.; Liu, P.; Wu, J.-J. |
| 臺大學術典藏 |
2020-05-04T08:02:24Z |
An energy-efficient task scheduler for multi-core platforms with per-core DVFS based on task characteristics
|
Lin, C.-C.;Chang, C.-J.;Syu, Y.-C.;Wu, J.-J.;Liu, P.;Cheng, P.-W.;Hsu, W.-T.; Lin, C.-C.; Chang, C.-J.; Syu, Y.-C.; Wu, J.-J.; Liu, P.; Cheng, P.-W.; Hsu, W.-T.; PANGFENG LIU |
| 臺大學術典藏 |
2020-05-04T08:02:23Z |
Job Dispatching and Scheduling for Heterogeneous Clusters-A Case Study on the Billing Subsystem of CHT Telecommunication
|
Lin, T.-C.;Lin, C.-C.;Chang, T.-W.;Liu, P.;Wu, J.-J.;Shih, C.-C.;Huang, C.-W.; Lin, T.-C.; Lin, C.-C.; Chang, T.-W.; Liu, P.; Wu, J.-J.; Shih, C.-C.; Huang, C.-W.; PANGFENG LIU |
| 臺大學術典藏 |
2020-05-04T08:02:19Z |
Communication Scheduling Optimization for Distributed Deep Learning Systems
|
PANGFENG LIU; Wu, J.-J.; Tsai, C.-Y.;Lin, C.-C.;Liu, P.;Wu, J.-J.; Tsai, C.-Y.; Lin, C.-C.; Liu, P. |
| 臺大學術典藏 |
2020-05-04T07:56:29Z |
Decapitation via digital epidemics: A bio-inspired transmissive attack
|
Chen, P.-Y.; Lin, C.-C.; Cheng, S.-M.; Hsiao, H.-C.; Huang, C.-Y.; HSU-CHUN HSIAO |
| 臺大學術典藏 |
2020-05-04T07:56:28Z |
Traffic-aware patching for cyber security in mobile IoT
|
Cheng, S.-M.; Chen, P.-Y.; Lin, C.-C.; Hsiao, H.-C.; HSU-CHUN HSIAO |
| 臺大學術典藏 |
2020-04-28T07:25:40Z |
A pilot study of AFL-T (doxorubicin, 5-fluorouracil, leucovorin, and tamoxifen) combination chemotherapy for hormone-refractory prostate cancer
|
Lin C.-C.;Chih-Hung Hsu;Chen J.;Tsai T.-C.;Cheng A.-L.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Chen J.; Tsai T.-C.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:38Z |
A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil
|
Chih-Hung Hsu;Cheng A.-L.;Hsu C.;Yang C.-H.;Lu Y.-S.;Lin C.-C.;Bu C.-F.;Yeh K.-H.; CHIH-HUNG HSU; Cheng A.-L.; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; Yeh K.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:34Z |
Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study
|
Lin C.-C.;Chih-Hung Hsu;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:34Z |
Weekly cisplatin plus infusional high-dose 5-fluorouracil and leucovorin (P-HDFL) for metastatic urothelial carcinoma: An effective regimen with low toxicity
|
Lin C.-C.;Chih-Hung Hsu;Huang C.-Y.;Cheng A.-L.;Chen J.;Vogelzang N.J.;Pu Y.-S.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Cheng A.-L.; Chen J.; Vogelzang N.J.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:32Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Pu Y.-S.;Cheng A.-L.;Huang K.-H.;Tsai Y.-C.;Huang C.-Y.;CHIH-HUNG HSU;Lin C.-C.; Lin C.-C.; CHIH-HUNG HSU; Huang C.-Y.; Tsai Y.-C.; Huang K.-H.; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2020-04-28T07:25:31Z |
Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma
|
CHIH-HUNG HSU;Cheng A.-L.;Hsu W.-L.;Tsai Y.-C.;Hsu C.;Yang C.-H.;Yeh K.-H.;Lin C.-C.; Lin C.-C.; Yeh K.-H.; Yang C.-H.; Hsu C.; Tsai Y.-C.; Hsu W.-L.; Cheng A.-L.; CHIH-HUNG HSU |
| 臺大學術典藏 |
2020-04-28T07:25:30Z |
Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study
|
Lin C.-C.; Lee J.-M.; Chang Y.-L.; CHIH-HUNG HSU; Tsai Y.-C.; Lee Y.-C.; Cheng J.C.-H.; Cheng J.C.-H.;Lee Y.-C.;Tsai Y.-C.;CHIH-HUNG HSU;Chang Y.-L.;Lee J.-M.;Lin C.-C.;Hsu F.-M.; Hsu F.-M. |
| 臺大學術典藏 |
2020-04-28T07:25:30Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H.; CHIH-HUNG HSU; Yu C.-J.; Chang Y.-C.; Hsu C.; Yang C.-H.;Yang P.-C.;Cheng A.-L.;Lin C.-C.;CHIH-HUNG HSU;Yu C.-J.;Chang Y.-C.;Hsu C.;Lin Z.-Z.; Lin Z.-Z. |
| 臺大學術典藏 |
2020-04-28T07:25:28Z |
Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy
|
Hsu F.-M.;Lee Y.-C.;Lee J.-M.;Chih-Hung Hsu;Lin C.-C.;Tsai Y.-C.;Wu J.-K.;Cheng J.C.-H.; Hsu F.-M.; Lee Y.-C.; Lee J.-M.; CHIH-HUNG HSU; Lin C.-C.; Tsai Y.-C.; Wu J.-K.; Cheng J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:28Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; Huang K.-H.; Cheng A.-L.; Pu Y.-S.; CHIH-HUNG HSU; Lin C.-C.;Chih-Hung Hsu;Cheng J.C.;Huang C.-Y.;Tsai Y.-C.;Hsu F.-M.;Huang K.-H.;Cheng A.-L.;Pu Y.-S.; Lin C.-C. |
| 臺大學術典藏 |
2020-04-28T07:25:25Z |
Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma
|
Huang P.-M.; Lee J.-M.; Hsu F.-M.; Hsu F.-M. ;Lee J.-M. ;Huang P.-M. ;Lin C.-C. ;Chih-Hung Hsu ;Tsai Y.-C. ;Lee Y.-C. ;Chia-Hsien Cheng J.; Lin C.-C.; CHIH-HUNG HSU; Tsai Y.-C.; Lee Y.-C.; Chia-Hsien Cheng J. |
| 臺大學術典藏 |
2020-04-28T07:25:19Z |
A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
|
Lin C.-C.;Su W.-C.;Yen C.-J.;Chih-Hung Hsu;Su W.-P.;Yeh K.-H.;Lu Y.-S.;Cheng A.-L.;Huang D.C.-L.;Fritsch H.;Voss F.;Taube T.;Yang J.C.-H.; Lin C.-C.; Su W.-C.; Yen C.-J.; CHIH-HUNG HSU; Su W.-P.; Yeh K.-H.; Lu Y.-S.; Cheng A.-L.; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H. |
| 臺大學術典藏 |
2020-04-28T07:25:19Z |
Pathological stage after neoadjuvant chemoradiation and esophagectomy superiorly predicts survival in patients with esophageal squamous cell carcinoma
|
Hsu F.-M.; Chang Y.-L.; Hsieh M.-S.; CHIH-HUNG HSU; Wang C.-C.;Cheng J.C.-H.;Tsai C.-L.;Lee J.-M.;Huang P.-M.;Lin C.-C.;Chih-Hung Hsu;Hsieh M.-S.;Chang Y.-L.;Hsu F.-M.; Wang C.-C.; Cheng J.C.-H.; Tsai C.-L.; Lee J.-M.; Huang P.-M.; Lin C.-C. |
| 臺大學術典藏 |
2020-04-28T07:25:18Z |
Systematic review and network meta-analysis: Neoadjuvant chemoradiotherapy for locoregional esophageal cancer
|
Huang T.-C.;Chih-Hung Hsu;Lin C.-C.;Tu Y.-K.; Huang T.-C.; CHIH-HUNG HSU; Lin C.-C.; Tu Y.-K. |
| 臺大學術典藏 |
2020-04-28T07:25:17Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; Cheng A.-L.; CHIH-HUNG HSU; Lin C.-C.; Huang T.-C.; Guo J.-C.; Guo J.-C.;Huang T.-C.;Lin C.-C.;Hsieh M.-S.;Chang C.-H.;Huang P.-M.;Lee J.-M.;Hsu F.-M.;Cheng J.C.-H.;Wang H.-P.;Yeh K.-H.;Cheng A.-L.;Chih-Hung Hsu |
| 臺大學術典藏 |
2020-04-28T07:25:14Z |
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement
|
Tsai Y.-C.; Chiang Y.;Cheng J.C.-H.;Huang C.-Y.;Tsai Y.-C.;Lin C.-C.;Chih-Hung Hsu;Cheng A.-L.;Pu Y.-S.; Chiang Y.; Cheng J.C.-H.; Huang C.-Y.; Lin C.-C.; CHIH-HUNG HSU; Cheng A.-L.; Pu Y.-S. |
Showing items 1351-1375 of 2549 (102 Page(s) Totally)
<< < 50 51 52 53 54 55 56 57 58 59 > >>
View [10|25|50] records per page
